Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...

A voluntary rebate pilot for the 340B drug discount program is drawing attention as a potential way to address concerns over ...

Sino-American biotech BeOne Medicines has announced financial results from the second quarter of 2025. Product revenue ...

Texas, USA-based clinical-stage biotech Gameto, a clinical-stage biotechnology company developing stem cell-derived therapies ...

US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to ...

UK-based contract research development and manufacturing organization (CRDMO) Arcinova, a subsidiary of Quotient Sciences, ...

The US Food and Drug Administration approved New Jersey, USA-based Insmed’s (Nasdaq: INSM) fibrosis bronchiectasis (NCFB), a ...

With the threat of US tariffs on pharmaceuticals looming in the coming weeks, Morningstar DBRS has taken a closer look at ...

A San Francisco–based biotech company developing precision medicines through an integrated discovery platform that combines ...

Evotec SE (XETRA: EVT) reported second-quarter 2025 revenues of $188 million, down 6% year-on-year, as strength in its biologics division partly offset weaker demand in discovery and preclinical ...

An Expert View from Lindsay Mateo, chief commercial officer at Weave Bio.

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...